Skip to main content
Clinical Trials/CTRI/2020/11/029132
CTRI/2020/11/029132CompletedPhase 3

Rotational Thromboelastometry( ROTEM) Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial

ILBS hospital0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Children less than 18 years of age with histologic or image proven liver cirrhosis of any etiology with INR ââ?°Â¥ 1.5- ââ?°Â¤ 2.5 and/or PLT count 20,000/mm3- 50,000/mm3 and who are listed for the following invasive procedures :
  • •Low risk of bleeding
  • •Central venous cannulation
  • •Haemodialysis catheter
  • •Ascitic or Pleural tapping
  • •High risk of bleeding
  • •ERCP with sphicterotomy
  • •PCD Insertion
  • •Biopsies other than liver biopsy
  • •Children less than 18 years of age with histologic or image proven liver cirrhosis of any etiology with INR ââ?°Â¥ 1.5- ââ?°Â¤ 2.0 and/or PLT count 40,000/mm3- 60,000/mm3 and who are listed for Liver biopsy

Exclusion Criteria

  • •Anti platelet or anti coagulant therapy in the previous 7 days
  • •Patients with clinical evidence of DIC and/or active bleeding
  • •Hemodialysis in the past 7 days

Investigators

Sponsor
ILBS hospital

Similar Trials